SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-008547
Filing Date
2023-03-22
Accepted
2023-03-22 16:30:14
Documents
12
Period of Report
2023-03-22
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 36392
  Complete submission text file 0001493152-23-008547.txt   210397

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE pcsa-20230322.xsd EX-101.SCH 3245
3 XBRL LABEL FILE pcsa-20230322_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE pcsa-20230322_pre.xml EX-101.PRE 22371
6 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3607
Mailing Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076
Business Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076 443-776-3133
Processa Pharmaceuticals, Inc. (Filer) CIK: 0001533743 (see all company filings)

IRS No.: 451539785 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39531 | Film No.: 23753294
SIC: 2834 Pharmaceutical Preparations